This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Business Development Remove Generic Pharmaceutical Remove Life Science Related Topics
Botox Bacterium Insulin Big Data Generic Drugs Cosmetics Dermatology Gene Editing FDA Approval Clinical Development More Related Topics >
article thumbnail

Excellence Awards 2022 – Winners Announced!

Pharmaceutical Technology

DECEMBER 22, 2022

The company has partnered with life sciences-focused investors Sixth Street and Royalty Pharma with an aim to bring substantial non-dilutive, low-cost capital to boost innovation and growth. It was also announced that the organisation would enter into collaboration with the Juvenile Diabetes Research Foundation (JDRF).

Insulin 130
Insulin Production Development Genetics 130
article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

AUGUST 2, 2023

They are committed to capitalizing on growth opportunities primarily through the advancement of their own product pipeline and constantly improving their existing products, as well as through business development activities. 2022 Revenue: In 2022, Merck KGaA (Life Science and Healthcare divisions only) had an annual revenue of €18.22

Sales 98
Sales Manufacturing FDA Approval Life Science 98
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024